In normal subjects, speed of psychomotor performance accounts for a significant portion of variance in tasks used for anxiolytic drug evaluation.
Answers are grounded in this paper and cite their sources.
Psychomotor variance may confound anxiolytic task interpretation in healthy subjects; hypothesis-generating and should not yet change trial design.
A battery of performance tasks together with some personality inventories commonly used in drug evaluation studies were administered to 60 normal subjects to study the intercorrelations among measures and to gain some preliminary indications of their factor structure. Speed of psychomotor performance accounted for 30% of the total variance.
No takes yet. Share an insight, caveat, or question.
Christa Zimmermann‐Tansella (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: